Learn More About Your
MyOme Personal Genome™
Proactive Health Report

Your MyOme Personal Genome Report identifies genetic variants in 81 genes identified by the American College of Medical Genetics and Genomics (ACMG) for their association with cancers, heart disease, metabolic conditions and other health risks, and for their actionability when used for early screening.

Understanding Your Results

proactive image

Understanding a Positive Result

A positive result means that you have a genetic variant that increases your risk for developing disease. Within the DNA we examined, we found a genetic variant that is listed as “Likely Pathogenic” or “Pathogenic” for that specific gene. We recommend that you follow up with your healthcare provider.

Download
proactive image

Understanding a Negative Result

A negative result means that MyOme did not find genetic variants known to increase your risk of developing a disease in the regions tested. Your risk for disease may be influenced by a combination of personal, lifestyle, genetic and/or environmental risk factors that MyOme did not analyze.

Download

Take Action

Based on your results, your healthcare provider can work with you to better manage and prevent disease. Actions may include:

action-img

Screening for disease

action-img

Guiding future family planning

action-img

Changing diet, lifestyle, exercise

action-img

Adding specialty healthcare providers to support you

action-img

Informing family members who may also be at-risk

Frequently Asked Questions

  • Clinical

  • Logistics

  • Support

  • Privacy

footer logo
linkedin

© 2024 MyOme.com

MyOme is not responsible for the content or accuracy of third-party websites

The MyOme Personal Genome™ Report was developed, and its performance characteristics were determined, by MyOme, Inc., a clinical laboratory certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high complexity clinical laboratory testing. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary for laboratory-developed tests.